Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bernfort

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
European Heart Journal|November 9, 2022
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP studyJohan Lyth, Emma Svennberg, Lars Bernfort, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 25, 2025
Cost-Effectiveness of Atrial Fibrillation Screening Programmes Across European NationsL Lars Bernfort, Johan Lyth, Kajsa Appelberg, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 5, 2024
The budget impact of implementing atrial fibrillation-screening in European countriesMichaela Eklund, Lars Bernfort, Kajsa Appelberg, et al.
Trials|June 21, 2025
Chronic cOronary Syndrome in Swedish PRImary care (COSPRI)-a study protocol for a 5-year cluster randomized controlled trial on a novel package versus standard investigation in patients with suspected chronic coronary syndrome referred from primary health careStaffan Nilsson, Fade Gabro, Erik Stertman, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
European Heart Journal|November 9, 2022
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP studyJohan Lyth, Emma Svennberg, Lars Bernfort, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 25, 2025
Cost-Effectiveness of Atrial Fibrillation Screening Programmes Across European NationsL Lars Bernfort, Johan Lyth, Kajsa Appelberg, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 5, 2024
The budget impact of implementing atrial fibrillation-screening in European countriesMichaela Eklund, Lars Bernfort, Kajsa Appelberg, et al.
Trials|June 21, 2025
Chronic cOronary Syndrome in Swedish PRImary care (COSPRI)-a study protocol for a 5-year cluster randomized controlled trial on a novel package versus standard investigation in patients with suspected chronic coronary syndrome referred from primary health careStaffan Nilsson, Fade Gabro, Erik Stertman, et al.
Pageof 5